ESC 365 - Welcome and introduction.

Open Access

Welcome and introduction.

Session: Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Topic: Atrial Fibrillation (AF)

Speaker: Doctor S. Saito (Kamakura, JP)

Sponsored by Daiichi Sankyo Europe GmbH

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Shigeru Saito

Shonan Kamakura General Hospital, Kamakura (Japan)

2 presentations

0 follower

3 more presentations in this session

Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Speaker: Professor N. van Mieghem (Rotterdam, NL)

New developments in NOACs and TAVI: How do we apply them in clinical practice?

Speaker: Professor D. Capodanno (Catania, IT)

Panel discussion.

Access the full session

Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Speakers: Doctor S. Saito, Professor N. van Mieghem, Professor D. Capodanno

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by